A new workflow of the on-line 1.5-T MR-guided adaptive radiation therapy

被引:0
作者
Takashi Uno
Masato Tsuneda
Kota Abe
Yukio Fujita
Rintaro Harada
Makoto Saito
Aki Kanazawa
Asuka Kodate
Yukinao Abe
Yohei Ikeda
Miho Watanabe Nemoto
Hajime Yokota
机构
[1] Chiba University,Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine
[2] Chiba University,Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine
[3] Chiba University Hospital,Department of Radiology
来源
Japanese Journal of Radiology | 2023年 / 41卷
关键词
MRgART; MR-Linac; Workflow; Adaptive radiation therapy; Adapt to shape;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1316 / 1322
页数:6
相关论文
共 111 条
[1]  
Lagendijk JJW(2008)MRI/linac integration Radiother Oncol 86 25-29
[2]  
Raaymakers BW(2014)The magnetic resonance imaging-linac system Semin Radiat Oncol 24 207-209
[3]  
Raaijmakers AJE(2018)Beam characterisation of the 1.5 T MRI-linac Phys Med Biol. 63 085015-50
[4]  
Overweg J(2017)First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment Phys Med Biol 62 L41-59
[5]  
Brown KJ(2019)Adaptive radiotherapy: the Elekta Unity MR-Linac concept Clin Trans Radiat Oncol 18 54-740
[6]  
Kerkhof EM(2022)Practical guidelines of online MR-guided adaptive radiotherapy J Radiat Res 63 730-4
[7]  
Lagendijk JJA(2019)Feasibility of stereotactic radiotherapy using a 1.5 T MR-Linac: multi-fraction treatment of pelvic lymph node oligometastases Radiother Oncol. 134 50-7
[8]  
Raaymakers BW(2019)First clinical experiences with a high field 1.5 T MR linac Acta Oncol. 58 1352-42
[9]  
van Vulpen M(2020)Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-Linac: initial clinical experiences and assessment of delivered doses compared to a C-arm linac Clin Transl Radiat Oncol 23 35-79
[10]  
Woodings SJ(2020)4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: implementation and initial clinical experience Clin Transl Radiat Oncol 23 72-8